On August 22, 2024, the FDA authorized new Covid-19 vaccines (2024-2025) “to include a monovalent (single) component that corresponds to the Omicron variant KP.2 strain of SARS-CoV-2. The mRNA COVID-19 vaccines have been updated with this formula to more closely target currently circulating variants and provide better protection against serious consequences of COVID-19, including hospitalization and death. Today’s actions relate to updated mRNA COVID-19 vaccines manufactured by ModernaTX Inc. and Pfizer Inc.”
● About Me
I’m Jim Amos MD, the creator and author behind this blog. I’m a retired psychiatrist who enjoys playing cribbage, juggling and still loves life-long learning. Watch out; I’m gonna pull your leg! Check out my YouTube site
Contact Form below:
Go Retire Psychiatrist 
Leave a comment